Latest News
Lung cancer risk assessment could be improved over existing guidelines by a four-protein biomarker blood test.
Scientists have made a major discovery about how cells repair broken strands of DNA that could have huge implications for the treatment of cancer.
In May and June several oncology drugs have been newly approved or been designated a new indication by the FDA.
Journal Articles
This database study demonstrates variations in the utilization of hematopoietic cell transplantation in adult patients with acute lymphoblastic leukemia based on several biological and non-biological factors.
Find out more about the utility of clinical characteristics in the selection of patients with advanced NSCLC as potential candidates for single-agent anti-PD-1/PD-L1 immunotherapy in this open access Future Oncology review article.
Find out about the healthcare utilization and costs associated with diffuse large B-cell & follicular lymphoma patients treated in the US in this research article from Future Oncology.
Brain and neurologic
Checkpoint blockade immunotherapy doubles survival for melanoma brain metastases patients
Glioblastoma vaccine yields promising interim survival results in Phase III trial
Intracranial meningioma with carcinoma tumor-to-tumor metastasis: two case reports
Breast
Promising Phase 1b clinical trial results of tucatinib with T-DM1 against HER2+ breast cancer
IMpassion130: first positive Phase III immunotherapy study in TNBC
Colorectal
ASCO18: PRODIGE 7 demonstrates that HIPEC may not be necessary for CRC patients
ASCO18: MSI-H tumor patients more likely to have Lynch Syndrome, genomic study demonstrates
Endocrine
Sodium thiosulphate halves hearing loss in children following cancer treatment
ASCO18: Is surgery necessary for advanced kidney cancer?
Nivolumab + ipilimumab combo approved as first-line treatment for advanced renal cell carcinoma
Gastrointestinal
Conference Chair highlights: World Congress on Gastrointestinal Cancer
Genitourinary
NICE approves atezolizumab for advanced bladder cancer patients on the NHS
Breakthrough method to diagnose prostate cancer developed
Researchers uncover 80 potential ways of targeting prostate cancer
Gynecologic
Ovarian cancer progression delayed by Lynparza® treatment
Vaccine success for cervical cancer: study reports fall in HPV infections
Cause of resistance to olaparib and other PARP inhibitors identified
Head and neck
The importance of a multidisciplinary team in the care of head and neck cancer
The importance of sentinel lymph node biopsies in the diagnosis of head and neck cancer
ASCO18: High dose of Nexium® with aspirin reduces risk of developing esophageal cancer
Hematologic
Economic burden of patients with diffuse large B-cell and follicular lymphoma treated in the USA
Lung
Protein-cased biomarker blood test improves assessment of lung cancer risk in smokers
Researchers create first comprehensive atlas of lung tumor cells
Pancreatic
ESMO WCGI: Study highlights first-line treatment variations for pancreatic cancer
ESMO WCGI: Adjuvant FOLFIRINOX new standard of care for pancreatic cancer
ASCO18: Preoperative chemoradiotherapy improves survival time for patients with pancreatic cancer
Prostate
New FDA oncology drug approvals and indications
Trace levels of CTCs could spot early signs of prostate cancer treatment ineffectiveness
Key mechanism that drives hormone therapy resistance in prostate cancer uncovered
Rare tumors
Osteoblastoma genetic marker shows promise for identifying aggressive tumors
Skin
New FDA oncology drug approvals and indications
Checkpoint blockade immunotherapy doubles survival for melanoma brain metastases patients
Deciding when to stop immunotherapy: exploring KEYNOTE-006 data
